Investors put $115M into Axonis amid revived interest in brain drugs https://t.co/q0nmbmFloI by @realJacobBell #startups
With $115 million, biotech startup Axonis Therapeutics pivots to burgeoning pain field https://t.co/yujGdkc6y5
With $115 million, biotech startup Axonis is pivoting to develop therapies in the burgeoning pain field. https://t.co/J9s5DTsUmx

INBRAIN Neuroelectronics, a Barcelona-based startup specializing in brain-computer interface technology, has successfully raised $50 million in a Series B funding round. The investment, led by Imec.xpand, will support the company's efforts to advance its graphene-based brain implant technology. INBRAIN aims to conduct a clinical trial involving 10 patients to further develop its innovative solutions for treating intractable diseases. This funding round highlights the growing interest in brain interface technologies and their potential applications in medical treatments.